Perrigo | PRGO - Przychody Ze Sprzedaży





Obroty Zmiana Data
AbbVie USD 16.62B 840M 2025-12
Abbott USD 11.16B 300M 2026-03
Bayer EUR 11.44B 1.78B 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Coherus Biosciences USD 12.75M 1.18M 2025-12
Corcept Therapeutics USD 202.12M 5.48M 2025-12
Dr.Reddys Laboratories INR 87.27B 780M 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
J&J USD 24.1B 500M 2026-03
Merck USD 16.4B 880M 2025-12
Nestle CHF 45.26B 1.03B 2025-12
Pacira USD 196.87M 17.35M 2025-12
Perrigo USD 1.11B 70M 2025-12
Pfizer USD 17.58B 880M 2025-12
Phibro Animal Health USD 373.91M 10.02M 2025-12
Prestige Brands USD 283.44M 9.34M 2025-12
Reckitt Benckiser GBP 7.26B 3.96B 2025-12
Sanofi EUR 11.24B 60M 2026-03
Supernus Pharmaceuticals USD 211.6M 19.5M 2025-12
Teva Pharmaceutical Industries USD 14.63B 10M 2025-12
Xeris Pharmaceuticals USD 85.81M 11.43M 2025-12
Zoetis USD 2.4B 0 2025-12